Atlas Trials

Nano-rheological Biomarkers for Patients With Sickle Cell Disease (SCD) Versus Control Subjects (Other Constitutional Red Blood Cell Diseases and Healthy Subjects)

Clinical trial NCT05530239 · UNKNOWN

Trial details

NCT number
NCT05530239
Sponsor
University Hospital, Grenoble
Status
UNKNOWN
Study type
OBSERVATIONAL
Sickle Cell Disease
Start date
2022-10-01
Primary completion
2024-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.